Literature DB >> 9255310

Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinoma.

R F Chuaqui1, C R Englert, S E Strup, C D Vocke, Z Zhuang, P H Duray, D G Bostwick, W M Linehan, L A Liotta, M R Emmert-Buck.   

Abstract

OBJECTIVES: To identify differentially expressed genes in tumor cells of patients with prostate cancer by means of tissue microdissection and targeted differential display.
METHODS: RNA was recovered from pure populations of microdissected normal epithelium and invasive tumor from frozen tissue sections of a radical prostatectomy specimen. Reverse transcription-polymerase chain reaction (PCR) using arbitrary and zinc finger PCR primers was performed.
RESULTS: A 130-base pair product was identified that appeared selectively in the tumor sample. DNA sequence analysis revealed it to be a clone from the expressed sequence tag database (GenBank accession R00504). Microdissection of normal epithelium and the corresponding invasive tumor was subsequently performed on a test panel of 10 prostate carcinoma specimens. Comparison of R00504 levels in normal epithelium and invasive carcinoma, using beta-actin as an internal control, showed the transcript to be substantially overexpressed in 5 of 10 carcinomas. Northern blotting revealed R00504 to be a 2.6-kilobase gene.
CONCLUSIONS: A novel transcript up-regulated in an aggressive prostate carcinoma was identified using degenerate zinc finger primers in microdissected tissue samples. The approach used in this study may be helpful in quantitative comparison of known genes and identification of novel genes in microdissected human tissue samples.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9255310     DOI: 10.1016/s0090-4295(97)00194-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

Review 1.  Molecular profiling of clinical tissues specimens: feasibility and applications.

Authors:  M R Emmert-Buck; R L Strausberg; D B Krizman; M F Bonaldo; R F Bonner; D G Bostwick; M R Brown; K H Buetow; R F Chuaqui; K A Cole; P H Duray; C R Englert; J W Gillespie; S Greenhut; L Grouse; L W Hillier; K S Katz; R D Klausner; V Kuznetzov; A E Lash; G Lennon; W M Linehan; L A Liotta; M A Marra; P J Munson; D K Ornstein; V V Prabhu; C Prang; G D Schuler; M B Soares; C M Tolstoshev; C D Vocke; R H Waterston
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

Review 2.  Molecular profiling of clinical tissue specimens: feasibility and applications.

Authors:  M R Emmert-Buck; R L Strausberg; D B Krizman; M F Bonaldo; R F Bonner; D G Bostwick; M R Brown; K H Buetow; R F Chuaqui; K A Cole; P H Duray; C R Englert; J W Gillespie; S Greenhut; L Grouse; L W Hillier; K S Katz; R D Klausner; V Kuznetzov; A E Lash; G Lennon; W M Linehan; L A Liotta; M A Marra; P J Munson; D K Ornstein; V V Prabhu; C Prange; G D Schuler; M B Soares; C M Tolstoshev; C D Vocke; R H Waterston
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

3.  Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures.

Authors:  Dejan Juric; Sanja Sale; Robert A Hromas; Ron Yu; Yan Wang; George E Duran; Robert Tibshirani; Lawrence H Einhorn; Branimir I Sikic
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-23       Impact factor: 11.205

4.  The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.

Authors:  Yuexing Zhang; Xin-Wei Wang; Danijela Jelovac; Takeo Nakanishi; Myoung-Hee Yu; Damilola Akinmade; Olga Goloubeva; Douglas D Ross; Angela Brodie; Anne W Hamburger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

Review 5.  PET Tracers Beyond FDG in Prostate Cancer.

Authors:  David M Schuster; Cristina Nanni; Stefano Fanti
Journal:  Semin Nucl Med       Date:  2016-09-07       Impact factor: 4.446

Review 6.  L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.

Authors:  Qian Wang; Jeff Holst
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

7.  Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters.

Authors:  Hiroyuki Okudaira; Shuntaro Oka; Masahiro Ono; Takeo Nakanishi; David M Schuster; Masato Kobayashi; Mark M Goodman; Ikumi Tamai; Keiichi Kawai; Yoshifumi Shirakami
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

8.  Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis.

Authors:  F Fend; M R Emmert-Buck; R Chuaqui; K Cole; J Lee; L A Liotta; M Raffeld
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

Review 9.  Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment.

Authors:  Keitaro Hayashi; Naohiko Anzai
Journal:  World J Gastrointest Oncol       Date:  2017-01-15

10.  Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs.

Authors:  S Li; E Hanna; R Breau; V Ratanatharathorn; X Xia; J Suen
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.